We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

QuantiFERON Change During Anti-tuberculosis Medication

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01038830
First Posted: December 24, 2009
Last Update Posted: June 14, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Armed Forces Capital Hospital, Republic of Korea
  Purpose
The aim of this study is to evaluate the change of QuantiFERON-TB gold in tube assay (QFT) during the treatment of active tuberculosis.

Condition
Tuberculosis Interferon-gamma Release Assay

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Change in Level of Interferon-gamma Assay in Active Tuberculosis Patients During Treatment

Resource links provided by NLM:


Further study details as provided by Armed Forces Capital Hospital, Republic of Korea:

Estimated Enrollment: 50
Study Start Date: May 2008
Study Completion Date: May 2010
Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Detailed Description:
Patients with active pulmonary tuberculosis are enrolled and, QFTs are performed for each subjects before treatment and 1, 3, 6 months after treatment. Investigators check the level of interferon-gamma, and reversion and conversion of this test.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Young healthy subjects in Korean military
Criteria

Inclusion Criteria:

  • All subjects with active tuberculosis

Exclusion Criteria:

  • Subjects who cannot complete study
  • Subjects who have taken anti-tuberculosis medication for more than a month before visit of our hospital
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01038830


Locations
Korea, Republic of
Armed Forces Capital Hospital
Seongnam, Gyeonggi-do, Korea, Republic of, 463-040
Sponsors and Collaborators
Armed Forces Capital Hospital, Republic of Korea
  More Information

Responsible Party: Sei Won Lee/Division chief of pulmonology, Armed Forces Capital Hospital
ClinicalTrials.gov Identifier: NCT01038830     History of Changes
Other Study ID Numbers: QFTchange
First Submitted: December 23, 2009
First Posted: December 24, 2009
Last Update Posted: June 14, 2010
Last Verified: December 2009

Additional relevant MeSH terms:
Tuberculosis
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections